Shinil Hospital Implements Daewoong Pharmaceutical's AI Bed Monitoring System 'thynC'

Enhancing Patient Safety and Improving Medical Staff Efficiency

Daewoong Pharmaceutical announced on January 23 that Shinil Hospital, located in Gangbuk-gu, Seoul, has become the first secondary medical institution in the region to implement the artificial intelligence (AI)-based bed monitoring system 'thynC' across all hospital beds.

Medical staff at Shinil Hospital are checking patient conditions while viewing the bed monitoring system Think. Daewoong Pharmaceutical

According to Daewoong Pharmaceutical, Shinil Hospital decided to introduce the AI-based bed monitoring system in order to establish a ward environment where changes in patient conditions can be identified in real time and emergency situations can be addressed promptly. The newly introduced thynC system has been applied to all 52 beds, with plans to expand its use as the number of beds increases in the future.

thynC is an integrated bed monitoring system that automatically detects patients' vital signs, movements, and abnormal conditions 24 hours a day, providing real-time alerts to medical staff. This enables healthcare professionals to recognize changes in patient conditions early and respond quickly. With the establishment of a continuous monitoring system, the burden on caregivers to stay at the bedside is reduced, and patients are expected to be able to focus on treatment in a more stable environment.

The system also significantly improves the work environment for medical staff. As repetitive tasks such as measuring and recording vital signs are automated, healthcare professionals can devote more time to diagnosis, decision-making, patient explanations, and emotional care. This is expected to enhance the efficiency of ward operations and improve the quality of medical care and nursing.

Shinil Hospital serves as a key regional hospital in Gangbuk-gu, operating an emergency surgery system and health check-up center 365 days a year, with a focus on internal medicine and surgery.

Yoo Inhyup, Director of Shinil Hospital, stated, "The introduction of the AI bed monitoring system is significant in that it has shifted the standard of ward operation from a work-centered approach to one focused on patient safety and comfort. This is the first step toward realizing a patient-centered ward and becoming a hospital trusted by the local community."

Park Hyungchul, Head of ETC Marketing Division at Daewoong Pharmaceutical, said, "thynC is a digital healthcare solution that reduces the burden on medical sites while enhancing patient safety. We will continue to expand our role as a partner that supports qualitative transformation in hospital operations through AI-based technology."

This content was produced with the assistance of AI translation services.